Decreased heart rate variability in transgenic mice overexpressing atrial beta(1)-adrenoceptors

被引:72
作者
Mansier, P
Medigue, C
Charlotte, N
Vermeiren, C
Coraboeuf, E
Deroubai, E
Ratner, E
Chevalier, B
Clairambault, J
Carre, F
Dahkli, T
Bertin, B
Briand, P
Strosberg, D
Swynghedauw, B
机构
[1] HOP LARIBOISIERE, INSERM, U127, F-75010 PARIS, FRANCE
[2] HOP LARIBOISIERE, INST FEDERATIF RECH CIRCULAT LARIBOISIERE, F-75010 PARIS, FRANCE
[3] INST NATL RECH INFORMAT & AUTOMAT DOMAINE VOLUCEA, F-75118 LE CHESNAY, FRANCE
[4] UNIV PARIS 11, LAB PHYSIOL CELLULAIRE, ORSAY, FRANCE
[5] FAC MED, LAB PHYSIOL MED, F-35042 RENNES, FRANCE
[6] INST COCHIN GENET MOL, LAB IMMUNOPHARMACOL MOL, F-75014 PARIS, FRANCE
[7] INST COCHIN GENET MOL, LAB GENET & PATHOL EXPT, F-75014 PARIS, FRANCE
[8] INST EXPT CARDIOL, LAB EXPT ENDOCRINOL, MOSCOW, RUSSIA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1996年 / 271卷 / 04期
关键词
Wigner-Ville transformation; phase-portrait maps; telemetry; spectral analysis; propranolol; isoproterenol;
D O I
10.1152/ajpheart.1996.271.4.H1465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart rate variability (HRV) depends on various reflexes, including the baroreflex or respiratory reflex. Experimental studies have suggested that the sinoatrial node density in G protein-linked receptors may be involved. Transgenic mice, with a specific eightfold atrial overexpression of human beta(1)-adrenoceptor (beta(1)-AR), have been generated to evaluate the role of the atrial beta(1)-AR density on HRV. The heart rate was monitored using telemetry, and the signal was analyzed using a quantitative time-frequency domain analysis, the smoothed pseudo-Wigner-Ville method, and phase portrait maps. 1) Heart rate was unchanged, but the two normal components of HRV were decreased in transgenic mice. Transgenic mice have an unshortened life span and no arrhythmias. 2) Challenge of the animals by propranolol showed no modulation of the HRV in transgenic mice compared with controls. 3) In isolated atrial strips from transgenic mice, basal contractility was increased and there was no isoproterenol-induced inotropic effect. 4) The basal level of adenosine 3',5'-cyclic monophosphate production was lowered in transgenic mice, suggesting a shift in adenylate cyclase isoforms.
引用
收藏
页码:H1465 / H1472
页数:8
相关论文
共 27 条
[1]   POWER SPECTRUM ANALYSIS OF HEART-RATE FLUCTUATION - A QUANTITATIVE PROBE OF BEAT-TO-BEAT CARDIOVASCULAR CONTROL [J].
AKSELROD, S ;
GORDON, D ;
UBEL, FA ;
SHANNON, DC ;
BARGER, AC ;
COHEN, RJ .
SCIENCE, 1981, 213 (4504) :220-222
[2]   QUANTITATIVE MODELING AND BIOLOGY - THE MULTIVARIATE APPROACH [J].
BENIGNI, R ;
GIULIANI, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :R1697-R1704
[3]   CORRELATIONS AMONG TIME AND FREQUENCY-DOMAIN MEASURES OF HEART PERIOD VARIABILITY 2 WEEKS AFTER ACUTE MYOCARDIAL-INFARCTION [J].
BIGGER, JT ;
FLEISS, JL ;
STEINMAN, RC ;
ROLNITZKY, LM ;
KLEIGER, RE ;
ROTTMAN, JN .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (09) :891-898
[4]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[5]   HEART-RATE-VARIABILITY IN 2 MODELS OF CARDIAC-HYPERTROPHY IN RATS IN RELATION TO THE NEW MOLECULAR PHENOTYPE [J].
CARRE, F ;
MAISONBLANCHE, P ;
OLLIVIER, L ;
MANSIER, P ;
CHEVALIER, B ;
VICUNA, R ;
LESSARD, Y ;
COUMEL, P ;
SWYNGHEDAUW, B .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :H1872-H1878
[6]   HEART-RATE-VARIABILITY IN LEFT-VENTRICULAR HYPERTROPHY AND HEART-FAILURE, AND THE EFFECTS OF BETA-BLOCKADE - A NON-SPECTRAL ANALYSIS OF HEART-RATE-VARIABILITY IN THE FREQUENCY-DOMAIN AND IN THE TIME DOMAIN [J].
COUMEL, P ;
HERMIDA, JS ;
WENNERBLOM, B ;
LEENHARDT, A ;
MAISONBLANCHE, P ;
CAUCHEMEZ, B .
EUROPEAN HEART JOURNAL, 1991, 12 (03) :412-422
[7]   FASCINATING RHYTHM - A PRIMER ON CHAOS THEORY AND ITS APPLICATION TO CARDIOLOGY [J].
DENTON, TA ;
DIAMOND, GA ;
HELFANT, RH ;
KHAN, S ;
KARAGUEUZIAN, H .
AMERICAN HEART JOURNAL, 1990, 120 (06) :1419-1440
[8]  
FIELD L, 1992, TRENDS CARDIOVAS MED, V2, P237
[9]  
FLANDRIN P, 1983, SIGNAL PROCESSINGS, V2, P455
[10]  
GLASS L, 1993, MED PROG TECHNOL, V19, P115